Expression Pathology Aids Research In Identifying Biomarkers Of Lung Cancer Metastasis And Survival

Expression Pathology Inc. (EPI), a leader in tissue proteomics, announced that researchers at Tokyo Medical University, using the company’s tissue microproteomics technologies, identified protein biomarkers associated with lung cancer metastasis, which were further studied for correlation to clinical outcomes.

More: continued here

Filed under: Lung Cancer on February 26th, 2008